BioPharmSignal logoBioPharmSignal
LiveFeedNotificationBlogPricing
Login

Blog Tag

Surrogate Endpoint

2 articles tagged with Surrogate Endpoint. The newest post is from Feb 22, 2026.

Back to all tagsBack to blog
02/22/2026

What Is a Surrogate Endpoint?

A surrogate endpoint is a clinical trial endpoint that stands in for a direct measure of how a patient feels, functions, or survives. Instead of waiting for a long-term clinical outcome, researchers use a surrogate that is reasonably expected to predict benefit. In biotech, surrogate endpoints are especially important because they can make development and approval faster in settings where waiting for the final outcome would take too long.

02/17/2026

What Is Accelerated Approval?

Accelerated approval is an FDA pathway that allows certain drugs for serious conditions to be approved based on a surrogate endpoint or another intermediate clinical measure that is reasonably likely to predict benefit. In biotech, the pathway matters because it can bring promising therapies to patients sooner when waiting for traditional long-term outcomes would be impractical.

BioPharmSignal ©2026

Track biotech catalysts, news, and alerts in one place.

Product

  • Pricing
  • LiveFeed

Integrations

  • Feishu / Lark Integration
  • Slack Integration
  • Discord Integration
  • DingTalk Integration

Resources

  • Blog
  • Privacy
  • Terms
  • Sitemap
Information only - not investment advice.